Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B6104 BVT 2733Summary: 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor -
A1624 Zaragozic Acid ASummary: rat liver squalene synthase inhibitor -
A3837 DL-α-Hydroxyglutaric acid disodium saltSummary: alpha hydroxy acid -
B6121 3-DeazaadenosineTarget: S-adenosylhomocysteine hydrolaseSummary: S-Adenosylhomocysteine (SAH) hydrolase inhibitor -
A1606 L-a-Hydroxyglutaric acid disodium saltSummary: salt form of L-α-Hydroxyglutaric acid -
B6124 FomepizoleSummary: competitive inhibitor of the enzyme alcohol dehydrogenase -
B6125 Acetazolamide2 CitationSummary: carbonic anhydrase (CA) inhibitor -
B6128 Fenofibric acidSummary: ppar inhibitor, lipid-lowering agent -
A4015 Disulfiram2 CitationTarget: Aldehyde DehydrogenasesSummary: Dopamine β-hydroxylase inhibitor -
A4054 17-AAG (KOS953)3 CitationSummary: Hsp90 inhibitor

